Adagene/$ADAG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Adagene
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
Ticker
$ADAG
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
138
Website
Adagene Metrics
BasicAdvanced
$95M
-
-$0.74
0.50
-
Price and volume
Market cap
$95M
Beta
0.5
52-week high
$3.20
52-week low
$1.33
Average daily volume
88K
Financial strength
Current ratio
2.299
Quick ratio
2.231
Long term debt to equity
1.108
Total debt to equity
36.604
Interest coverage (TTM)
-42.20%
Profitability
EBITDA (TTM)
-35.229
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-32,386.45%
Operating margin (TTM)
-34,836.72%
Effective tax rate (TTM)
0.05%
Management effectiveness
Return on assets (TTM)
-21.92%
Return on equity (TTM)
-55.21%
Valuation
Price to revenue (TTM)
877.346
Price to book
1.87
Price to tangible book (TTM)
1.87
Price to free cash flow (TTM)
-3.044
Free cash flow yield (TTM)
-32.85%
Free cash flow per share (TTM)
-0.66
Growth
Revenue change (TTM)
-99.43%
Earnings per share change (TTM)
69.66%
3-year revenue growth (CAGR)
-78.35%
3-year earnings per share growth (CAGR)
-25.96%
What the Analysts think about Adagene
Analyst ratings (Buy, Hold, Sell) for Adagene stock.
Adagene Financial Performance
Revenues and expenses
Adagene Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Adagene stock?
Adagene (ADAG) has a market cap of $95M as of August 01, 2025.
What is the P/E ratio for Adagene stock?
The price to earnings (P/E) ratio for Adagene (ADAG) stock is 0 as of August 01, 2025.
Does Adagene stock pay dividends?
No, Adagene (ADAG) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next Adagene dividend payment date?
Adagene (ADAG) stock does not pay dividends to its shareholders.
What is the beta indicator for Adagene?
Adagene (ADAG) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.